Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3540)
PRECIGEN, INC. (PGEN)
Lehr Donald P. — Chief Legal Officer
Shares
29,131
Price
$4.36
Total Value
$127.01K
Shares Held After
755,461
% of Holdings
3.7%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,703
Price
$4.36
Total Value
$186.19K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
30,272
Price
$4.36
Total Value
$131.99K
Shares Held After
139,369
% of Holdings
17.8%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
41,884
Price
$4.36
Total Value
$182.61K
Shares Held After
554,535
% of Holdings
7.0%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,669
Price
$109.30
Total Value
$182.42K
Shares Held After
59,634
% of Holdings
2.7%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
900
Price
$108.14
Total Value
$97.33K
Shares Held After
61,303
% of Holdings
1.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,530
Price
$107.45
Total Value
$164.40K
Shares Held After
62,203
% of Holdings
2.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,401
Price
$106.32
Total Value
$148.95K
Shares Held After
63,733
% of Holdings
2.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
100
Price
$109.76
Total Value
$10.98K
Shares Held After
58,117
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,500
Price
$109.30
Total Value
$163.95K
Shares Held After
58,217
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,178
Price
$108.01
Total Value
$127.24K
Shares Held After
59,717
% of Holdings
1.9%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,422
Price
$107.33
Total Value
$152.62K
Shares Held After
60,895
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,300
Price
$106.26
Total Value
$138.14K
Shares Held After
62,317
% of Holdings
2.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
47,122
% of Holdings
1.4%
Jazz Pharmaceuticals plc (JAZZ)
Pearce Samantha — EVP, Chief Commercial Officer
Shares
6,907
Price
$235.41
Total Value
$1.63M
Shares Held After
50,272
% of Holdings
12.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
27,698
Price
$0.46
Total Value
$12.74K
Shares Held After
655,135
% of Holdings
4.1%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
30,208
Price
$2.98
Total Value
$90.02K
Shares Held After
62,586
% of Holdings
32.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
200
Price
$2.71
Total Value
$542.00
Shares Held After
62,586
% of Holdings
0.3%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
55,604
Price
$2.70
Total Value
$150.13K
Shares Held After
62,786
% of Holdings
47.0%
Equillium, Inc. (EQ)
Tom Penny — Principal Accounting Officer
Shares
65,000
Price
$2.95
Total Value
$191.75K
Shares Held After
0
% of Holdings
100.0%
Immunovant, Inc. (IMVT)
Fromkin Andrew J. — Director
Shares
210,468
Price
$33.56
Total Value
$7.06M
Shares Held After
74,382
% of Holdings
73.9%
Immunovant, Inc. (IMVT)
Fromkin Andrew J. — Director
Shares
11,483
Price
$32.64
Total Value
$374.81K
Shares Held After
284,850
% of Holdings
3.9%
Annexon, Inc. (ANNX)
Satter Muneer A — Director
Shares
613,497
Price
$5.41
Total Value
$3.32M
Shares Held After
10,342,134
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$571.55
Total Value
$171.46K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
260
Price
$570.76
Total Value
$148.40K
Shares Held After
40,813
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
227
Price
$569.57
Total Value
$129.29K
Shares Held After
41,073
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
728
Price
$568.78
Total Value
$414.07K
Shares Held After
41,300
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,339
Price
$567.76
Total Value
$760.23K
Shares Held After
42,028
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,261
Price
$566.72
Total Value
$714.63K
Shares Held After
43,367
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$565.69
Total Value
$318.49K
Shares Held After
44,628
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$564.59
Total Value
$772.92K
Shares Held After
45,191
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,638
Price
$563.68
Total Value
$923.31K
Shares Held After
46,560
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$562.59
Total Value
$855.13K
Shares Held After
48,198
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
295
Price
$561.53
Total Value
$165.65K
Shares Held After
49,718
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
228
Price
$571.48
Total Value
$130.30K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
332
Price
$570.50
Total Value
$189.40K
Shares Held After
19,104
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
844
Price
$568.90
Total Value
$480.15K
Shares Held After
19,436
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,605
Price
$567.91
Total Value
$911.50K
Shares Held After
20,280
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
934
Price
$566.87
Total Value
$529.45K
Shares Held After
21,885
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
893
Price
$566.00
Total Value
$505.43K
Shares Held After
22,819
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,208
Price
$564.82
Total Value
$682.30K
Shares Held After
23,712
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,675
Price
$563.87
Total Value
$944.49K
Shares Held After
24,920
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,961
Price
$562.77
Total Value
$1.10M
Shares Held After
26,595
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$561.48
Total Value
$179.67K
Shares Held After
28,556
% of Holdings
1.1%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
148
Price
$32.67
Total Value
$4.84K
Shares Held After
833,694
% of Holdings
0.0%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
119,852
Price
$31.88
Total Value
$3.82M
Shares Held After
833,842
% of Holdings
12.6%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,989
Price
$4.93
Total Value
$14.74K
Shares Held After
182,161
% of Holdings
1.6%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,852
Price
$0.48
Total Value
$38.81K
Shares Held After
682,833
% of Holdings
10.6%
Showing 51–100 of 3540 transactions (page 2 of 71)